Brokerages Set Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX) PT at $11.60
Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX – Get Free Report) has earned an average recommendation of “Buy” from the five research firms that are currently covering the company, MarketBeat reports. Five analysts have rated the stock with a buy rating. The average twelve-month price objective among brokers that have issued a report on the stock in the […]
Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX – Get Free Report) has earned an average recommendation of “Buy” from the five research firms that are currently covering the company, MarketBeat reports. Five analysts have rated the stock with a buy rating. The average twelve-month price objective among brokers that have issued a report on the stock in the […]
